FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Norio Abiru

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Anatomy

Geographic Areas

Japan

Concepts & Ideas

Age of Onset

Co-author Network

Publications

TOP 3
Fumi Murata; Kan Nakamura; Ikuko Ueki; Hironori Yamasaki; Norio Abiru; Satoru Akazawa; Takao Ando; Hideyuki Hayashi; Ichiro Horie; Eriko Isomoto; Eiji Kawasaki; Masakazu Kobayashi; Hironaga Kuwahara; Atsushi Kawakami
A case of glycogenic hepatopathy developed in a patient with new-onset fulminant type 1 diabetes: the role of image modalities in diagnosing hepatic glycogen deposition including gradient-dual-echo MRI.
Yuji Nagayama; M Nakahara; M Shimamura; K Arima; I Horie; Norio Abiru
Prophylactic and therapeutic efficacies of a selective inhibitor of the immunoproteasome for Hashimoto's thyroiditis, but not for Graves' hyperthyroidism, in mice.
Ichiro Horie; Norio Abiru; Takao Ando; Eri Ejima; Eiji Kawasaki; Hironaga Kuwahara; Toshiro Usa; Hironori Yamasaki; Atsushi Kawakami
Clinical and genetic characteristics of autoimmune polyglandular syndrome type 3 variant in the Japanese population.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Norio Abiru (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Fumi Murata; Kan Nakamura; Ikuko Ueki; Hironori Yamasaki; Norio Abiru; Satoru Akazawa; Takao Ando; Hideyuki Hayashi; Ichiro Horie; Eriko Isomoto; Eiji Kawasaki; Masakazu Kobayashi; Hironaga Kuwahara; Atsushi Kawakami
A case of glycogenic hepatopathy developed in a patient with new-onset fulminant type 1 diabetes: the role of image modalities in diagnosing hepatic glycogen deposition including gradient-dual-echo MRI.
Endocrine journal 2012;59(8):669-76.
2012: Yuji Nagayama; M Nakahara; M Shimamura; K Arima; I Horie; Norio Abiru
Prophylactic and therapeutic efficacies of a selective inhibitor of the immunoproteasome for Hashimoto's thyroiditis, but not for Graves' hyperthyroidism, in mice.
Clinical and experimental immunology 2012;168(3):268-73.
2012: Ichiro Horie; Norio Abiru; Takao Ando; Eri Ejima; Eiji Kawasaki; Hironaga Kuwahara; Toshiro Usa; Hironori Yamasaki; Atsushi Kawakami
Clinical and genetic characteristics of autoimmune polyglandular syndrome type 3 variant in the Japanese population.
The Journal of clinical endocrinology and metabolism 2012;97(6):E1043-50.
2012: Masakazu Kobayashi; Norio Abiru
[Immune-regulation and clinical intervention in type 1 diabetes].
Nihon rinsho. Japanese journal of clinical medicine 2012;70 Suppl 3():342-5.
2012: Mami Nakahara; Ryo Taguchi; Masanobu Yamada; Norio Abiru; Anja Eckstein; Kristian Johnson; Yuji Nagayama
Adoptive transfer of antithyrotropin receptor (TSHR) autoimmunity from TSHR knockout mice to athymic nude mice.
Endocrinology 2012;153(4):2034-42.
2011: Eiji Kawasaki; Masakazu Kobayashi; Genpei Kuriya; Hironaga Kuwahara; Nobuo Matsuura; Junnosuke Miura; Kan Nakamura; Tsuyoshi Satoh; Yasuko Uchigata; Hironori Yamasaki; Norio Abiru; Katsumi Eguchi
Zinc transporter 8 autoantibodies in fulminant, acute-onset, and slow-onset patients with type 1 diabetes.
Diabetes/metabolism research and reviews 2011;27(8):895-8.
2011: Ichiro Horie; Yoichiro Iwakura; Norio Abiru; Hikaru Sakamoto; Yuji Nagayama
Induction of autoimmune thyroiditis by depletion of CD4+CD25+ regulatory T cells in thyroiditis-resistant IL-17, but not interferon-gamma receptor, knockout nonobese diabetic-H2h4 mice.
Endocrinology 2011;152(11):4448-54.
2011: Tomoki Origuchi; Satomi Yamaguchi; Norio Abiru; Akiyo Inoue; Atsushi Kawakami; Yoshie Kazaura; Naomi Matsuo; Katsumi Eguchi
Increased incidence of pre-diabetes mellitus at a department of rheumatology: a retrospective study.
Modern rheumatology / the Japan Rheumatism Association 2011;21(5):495-9.
2011: Ikuko Ueki; Norio Abiru; Kentaro Kawagoe; Yuji Nagayama
Interleukin 10 deficiency attenuates induction of anti-TSH receptor antibodies and hyperthyroidism in a mouse Graves' model.
The Journal of endocrinology 2011;209(3):353-7.
2011: I Ueki; Norio Abiru; M Kobayashi; M Nakahara; Tatsuki Ichikawa; Katsumi Eguchi; Yuji Nagayama
B cell-targeted therapy with anti-CD20 monoclonal antibody in a mouse model of Graves' hyperthyroidism.
Clinical and experimental immunology 2011;163(3):309-17.
2011: Ichiro Horie; Norio Abiru; Ohki Saitoh; Tatsuki Ichikawa; Yoichiro Iwakura; Katsumi Eguchi; Yuji Nagayama
Distinct role of T helper Type 17 immune response for Graves' hyperthyroidism in mice with different genetic backgrounds.
Autoimmunity 2011;44(2):159-65.
2011: Eiji Kawasaki; Kan Nakamura; Genpei Kuriya; Tsuyoshi Satoh; Masakazu Kobayashi; Hironaga Kuwahara; Norio Abiru; Hironori Yamasaki; Nobuo Matsuura; Junnosuke Miura; Yasuko Uchigata; Katsumi Eguchi
Differences in the humoral autoreactivity to zinc transporter 8 between childhood- and adult-onset type 1 diabetes in Japanese patients.
Clinical immunology (Orlando, Fla.) 2011;138(2):146-53.
2010: Yukiko Kagohashi; Norio Abiru; Masakazu Kobayashi; Michio Hashimoto; Osamu Shido; Hiroki Otani
Maternal dietary n-6/n-3 fatty acid ratio affects type 1 diabetes development in the offspring of non-obese diabetic mice.
Congenital anomalies 2010;50(4):212-20.
2010: Yui Sekitani; Naomi Hayashida; Koichiro Kadota; Hironori Yamasaki; Norio Abiru; Mio Nakazato; Takahiro Maeda; Yoshiyuki Ozono; Noboru Takamura
White blood cell count and cardiovascular biomarkers of atherosclerosis.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2010;15(5):454-60.
2010: Noboru Takamura; Naomi Hayashida; Kyoko Hagane; Koichiro Kadota; Hironori Yamasaki; Norio Abiru; Yoshiyuki Ozono; Shimeru Kamihira; Kiyoshi Aoyagi; Kiyomi Ishibashi; Mio Nakazato; Takahiro Maeda
Leptin to high-molecular-weight adiponectin ratio is independently correlated with carotid intima-media thickness in men, but not in women.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2010;15(4):340-4.
2010: Eiji Kawasaki; Kan Nakamura; Genpei Kuriya; Tsuyoshi Satoh; Hironaga Kuwahara; Masakazu Kobayashi; Norio Abiru; Hironori Yamasaki; Katsumi Eguchi
Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes.
The Journal of clinical endocrinology and metabolism 2010;95(2):707-13.
2010: Kan Nakamura; Eiji Kawasaki; Norio Abiru; Ozora Jo; Keiko Fukushima; Tsuyoshi Satoh; Genpei Kuriya; Masakazu Kobayashi; Hironaga Kuwahara; Hironori Yamasaki; Tatsuya Ide; Katsumi Eguchi
Trajectories of anti-islet autoantibodies before development of type 1 diabetes in interferon-treated hepatitis C patients. Case reports and a literature review.
Endocrine journal 2010;57(11):947-51.
2010: Ichiro Horie; Eiji Kawasaki; Aya Shimomura; Tsuyoshi Satoh; Ikuko Ueki; Hironaga Kuwahara; Takao Ando; Norio Abiru; Toshiro Usa; Katsumi Eguchi
Emergence of anti-islet autoantibodies in Japanese patients with type 1 diabetes.
Endocrine journal 2010;57(7):623-8.
2009: Ichiro Horie; Norio Abiru; Yuji Nagayama; Genpei Kuriya; Ohki Saitoh; Tatsuki Ichikawa; Yoichiro Iwakura; Katsumi Eguchi
T helper type 17 immune response plays an indispensable role for development of iodine-induced autoimmune thyroiditis in nonobese diabetic-H2h4 mice.
Endocrinology 2009;150(11):5135-42.
2009: Yuji Nagayama; Tatsuki Ichikawa; Ohki Saitoh; Norio Abiru
Induction of late-onset spontaneous autoimmune thyroiditis by a single low-dose irradiation in thyroiditis-prone non-obese diabetic-H2h4 mice.
Journal of radiation research 2009;50(6):573-7.
2009: Mami Nakahara; Yuji Nagayama; Ohki Saitoh; Rintaro Sogawa; Shigenobu Tone; Norio Abiru
Expression of immunoregulatory molecules by thyrocytes protects nonobese diabetic-H2h4 mice from developing autoimmune thyroiditis.
Endocrinology 2009;150(3):1545-51.
2008: Eiji Kawasaki; Miho Uga; K Nakamura; G Kuriya; T Satoh; K Fujishima; M Ozaki; Norio Abiru; Hironori Yamasaki; J M Wenzlau; H W Davidson; J C Hutton; Katsumi Eguchi
Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes.
Diabetologia 2008;51(12):2299-302.
2008: Keiko Fukushima; Norio Abiru; Yuji Nagayama; Masakazu Kobayashi; Tsuyoshi Satoh; Mami Nakahara; Eiji Kawasaki; Hironori Yamasaki; Satoshi Ueha; Koji Matsushima; Edwin Liu; Katsumi Eguchi
Combined insulin B:9-23 self-peptide and polyinosinic-polycytidylic acid accelerate insulitis but inhibit development of diabetes by increasing the proportion of CD4+Foxp3+ regulatory T cells in the islets in non-obese diabetic mice.
Biochemical and biophysical research communications 2008;367(4):719-24.
2007: Masakazu Kobayashi; Norio Abiru; Takeshi Arakawa; Keiko Fukushima; Hongbo Zhou; Eiji Kawasaki; Hironori Yamasaki; Edwin Liu; Dongmei Miao; F Susan Wong; George S Eisenbarth; Katsumi Eguchi
Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(4):2082-8.
2007: Akie Moriuchi; Hironori Yamasaki; Mika Shimamura; Atsushi Kita; Hironaga Kuwahara; Keiichiro Fujishima; Tsuyoshi Satoh; Keiko Fukushima; Tetsuya Fukushima; Takao Hayakawa; Hiroyuki Mizuguchi; Yuji Nagayama; Norio Abiru; Eiji Kawasaki; Katsumi Eguchi
Induction of human adiponectin gene transcription by telmisartan, angiotensin receptor blocker, independently on PPAR-gamma activation.
Biochemical and biophysical research communications 2007;356(4):1024-30.
2006: Naota Taura; Tatsuki Ichikawa; Keisuke Hamasaki; Kazuhiko Nakao; Daisuke Nishimura; Takashi Goto; Mariko Fukuta; Hiroshi Kawashimo; Masumi Fujimoto; Koichiro Kusumoto; Yasuhide Motoyoshi; Hidetaka Shibata; Norio Abiru; Hironori Yamasaki; Katsumi Eguchi
Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients.
The American journal of gastroenterology 2006;101(12):2752-9.
2006: Masako Tsurumaru; Eiji Kawasaki; Hiroaki Ida; Kiyoshi Migita; Akie Moriuchi; Keiko Fukushima; Tetsuya Fukushima; Norio Abiru; Hironori Yamasaki; Shinsuke Noso; Hiroshi Ikegami; Takuya Awata; Hitoshi Sasaki; Katsumi Eguchi
Evidence for the role of small ubiquitin-like modifier 4 as a general autoimmunity locus in the Japanese population.
The Journal of clinical endocrinology and metabolism 2006;91(8):3138-43.
2005: Atsushi Kita; Hironori Yamasaki; Hironaga Kuwahara; Akie Moriuchi; Keiko Fukushima; Masakazu Kobayashi; Tetsuya Fukushima; Ryoko Takahashi; Norio Abiru; Shigeo Uotani; Eiji Kawasaki; Katsumi Eguchi
Identification of the promoter region required for human adiponectin gene transcription: Association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha.
Biochemical and biophysical research communications 2005;331(2):484-90.
2005: Maki Nakayama; Norio Abiru; Hiroaki Moriyama; Naru Babaya; Edwin Liu; Dongmei Miao; Liping Yu; Dale R Wegmann; John C Hutton; John Elliott; George S Eisenbarth
Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.
Nature 2005;435(7039):220-3.
2004: Maki Nakayama; Hiroaki Moriyama; Norio Abiru; Sunanda R Babu; Kamila Sikora; Marcella Li; Dongmei Miao; John C Hutton; John Elliott; George S Eisenbarth
Establishment of native insulin-negative NOD mice and the methodology to distinguish specific insulin knockout genotypes and a B:16 alanine preproinsulin transgene.
Annals of the New York Academy of Sciences 2004;1037():193-8.
2004: Eiji Kawasaki; Akane Ide; Norio Abiru; Masakazu Kobayashi; Tetsuya Fukushima; Hironaga Kuwahara; Atsushi Kita; Shigeo Uotani; Hironori Yamasaki; Katsumi Eguchi
Stromal cell-derived factor-1 chemokine gene variant in patients with type 1 diabetes and autoimmune thyroid disease.
Annals of the New York Academy of Sciences 2004;1037():79-83.
2004: Eiji Kawasaki; Norio Abiru; Katsumi Eguchi
Prevention of type 1 diabetes: from the view point of beta cell damage.
Diabetes research and clinical practice 2004;66 Suppl 1():S27-32.
2004: Edwin Liu; Hiroaki Moriyama; Norio Abiru; Johanna Paronen; Devasenan Devendra; Fred D Finkelman; George S Eisenbarth
Preventing peptide-induced anaphylaxis: addition of C-terminal amino acids to produce a neutral isoelectric point.
The Journal of allergy and clinical immunology 2004;114(3):607-13.
2004: Akane Ide; Eiji Kawasaki; Norio Abiru; Fuyan Sun; Masakazu Kobayashi; Tetsuya Fukushima; Ryoko Takahashi; Hironaga Kuwahara; Atsushi Kita; Katsuya Oshima; Shigeo Uotani; Hironori Yamasaki; Yoshihiko Yamaguchi; Katsumi Eguchi
Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes.
Journal of autoimmunity 2004;22(1):73-8.
2003: Eiji Kawasaki; Norio Abiru; Akane Ide; Fuyan Sun; Tetsuya Fukushima; Ryoko Takahashi; Hironaga Kuwahara; Naruhiro Fujita; Atsushi Kita; Katsuya Oshima; Shigeo Uotani; Hironori Yamasaki; Yoshihiko Yamaguchi; Katsumi Eguchi
Epitope analysis of GAD65 autoantibodies in Japanese patients with autoimmune diabetes.
Annals of the New York Academy of Sciences 2003;1005():440-8.
2003: Akane Ide; Eiji Kawasaki; Norio Abiru; Fuyan Sun; Tetsuya Fukushima; Reiko Ishii; Ryoko Takahashi; Hironaga Kuwahara; Naruhiro Fujita; Atsushi Kita; Misa Imaizumi; Katsuya Oshima; Toshiro Usa; Shigeo Uotani; Eri Ejima; Hironori Yamasaki; Kiyoto Ashizawa; Yoshihiko Yamaguchi; Katsumi Eguchi
Association of interleukin-18 gene promoter polymorphisms in type 1 diabetes and autoimmune thyroid disease.
Annals of the New York Academy of Sciences 2003;1005():436-9.
2003: Akane Ide; Eiji Kawasaki; Norio Abiru; Fuyan Sun; Tetsuya Fukushima; Reiko Ishii; Ryoko Takahashi; Hironaga Kuwahara; Naruhiro Fujita; Atsushi Kita; Misa Imaizumi; Katsuya Oshima; Toshiro Usa; Shigeo Uotani; Eri Ejima; Hironori Yamasaki; Kiyoto Ashizawa; Yoshihiko Yamaguchi; Katsumi Eguchi
Interleukin-10 gene promoter region polymorphisms in patients with type 1 diabetes and autoimmune thyroid disease.
Annals of the New York Academy of Sciences 2003;1005():344-7.
2003: Norio Abiru; Fuyan Sun; Eiji Kawasaki; Hironori Yamasaki; Katsuya Oshima; Yuji Nagayama; Hiroyuki Mizuguchi; Takao Hayakawa; Dongmei Miao; Edwin Liu; George S Eisenbarth; Katsumi Eguchi
In vivo expression of B:9-23 peptide/I-A(g7) complex may abrogate the inhibition of diabetes induced by RGD-fiber-mutant adenovirus in NOD mice.
Annals of the New York Academy of Sciences 2003;1005():218-21.
2003: Johanna Paronen; Hiroaki Moriyama; Norio Abiru; Kamila Sikora; Evie Melanitou; Sunanda Babu; Fei Bao; Edwin Liu; Dongmei Miao; George S Eisenbarth
Establishing insulin 1 and insulin 2 knockout congenic strains on NOD genetic background.
Annals of the New York Academy of Sciences 2003;1005():205-10.
2003: Edwin Liu; Hiroaki Moriyama; Johanna Paronen; Norio Abiru; Dongmei Miao; Liping Yu; Robert M Taylor; George S Eisenbarth
Nondepleting anti-CD4 monoclonal antibody prevents diabetes and blocks induction of insulin autoantibodies following insulin peptide B:9-23 immunization in the NOD mouse.
Journal of autoimmunity 2003;21(3):213-9.
2003: Akane Ide; Eiji Kawasaki; Norio Abiru; Fuyan Sun; Tetsuya Fukushima; Ryoko Takahashi; Hironaga Kuwahara; Naruhiro Fujita; Atsushi Kita; Katsuya Oshima; Shigeo Uotani; Hironori Yamasaki; Yoshihiko Yamaguchi; Yumiko Kawabata; Tomomi Fujisawa; Hiroshi Ikegami; Katsumi Eguchi
Stromal-cell derived factor-1 chemokine gene variant is associated with type 1 diabetes age at onset in Japanese population.
Human immunology 2003;64(10):973-8.
2003: Hiroaki Moriyama; Norio Abiru; Johanna Paronen; Kamila Sikora; Edwin Liu; Dongmei Miao; Devasenan Devendra; Joshua Beilke; Roberto Gianani; Ronald G Gill; George S Eisenbarth
Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(18):10376-81.
2002: Edwin Liu; Hiroaki Moriyama; Norio Abiru; Dongmei Miao; Liping Yu; Robert M Taylor; Fred D Finkelman; George S Eisenbarth
Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23.
The Journal of clinical investigation 2002;110(7):1021-7.
2002: Norio Abiru; Eiji Kawasaki; Katsumi Eguch
Current knowledge of Japanese type 1 diabetic syndrome.
Diabetes/metabolism research and reviews 2002;18(5):357-66.
2002: H Takino; Hironori Yamasaki; Norio Abiru; Yasunori Sera; Takahiro Abe; Eiji Kawasaki; Yoshihiko Yamaguchi; Katsumi Eguchi; Y Kanazawa; Shigenobu Nagataki
Antibodies to GAD in Japanese patients classified as Type 2 diabetes at diagnosis. High titre of GAD Ab is a predictive marker for early insulin treatment--report of west Japan (Kyushu, Yamaguchi, Osaka) study for GAD Ab(+) diabetes.
Diabetic medicine : a journal of the British Diabetic Association 2002;19(9):730-4.
2002: Akane Ide; Eiji Kawasaki; Norio Abiru; Fuyan Sun; Ryoko Takahashi; Hironaga Kuwahara; Naruhiro Fujita; Atsushi Kita; Katsuya Oshima; Hiroyuki Sakamaki; Shigeo Uotani; Hironori Yamasaki; Yoshihiko Yamaguchi; Katsumi Eguchi
Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset.
Human immunology 2002;63(8):690-5.
2002: Hiroaki Moriyama; Li Wen; Norio Abiru; Edwin Liu; Liping Yu; Dongmei Miao; Roberto Gianani; F Susan Wong; George S Eisenbarth
Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(8):5539-44.
2002: Eiji Kawasaki; Yasunori Sera; Norio Abiru; Mikako Yamauchi; Masako Ozaki; Kenichi Yamakawa; Takahiro Abe; Shigeo Uotani; Hironori Yamasaki; Yoshihiko Yamaguchi; Katsumi Eguchi
Distinct IA-2 autoantibody epitope recognition between childhood-onset and adult-onset type 1 diabetes.
Annals of the New York Academy of Sciences 2002;958():235-40.
2002: Edwin Liu; Norio Abiru; Hiroaki Moriyama; Dongmei Miao; George S Eisenbarth
Induction of insulin autoantibodies and protection from diabetes with subcutaneous insulin B:9-23 peptide without adjuvant.
Annals of the New York Academy of Sciences 2002;958():224-7.
2001: W Chen; I Bergerot; John Elliott; L C Harrison; Norio Abiru; G S Eisenbarth; Terry L Delovitch
Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(9):4926-35.
2001: Norio Abiru; Liping Yu; Dongmei Miao; Aristides K Maniatis; Edwin Liu; Hiroaki Moriyama; George S Eisenbarth
Transient insulin autoantibody expression independent of development of diabetes: comparison of NOD and NOR strains.
Journal of autoimmunity 2001;17(1):1-6.
2001: Norio Abiru; Aristides K Maniatis; Liping Yu; Dongmei Miao; Hiroaki Moriyama; Dale R Wegmann; George S Eisenbarth
Peptide and major histocompatibility complex-specific breaking of humoral tolerance to native insulin with the B9-23 peptide in diabetes-prone and normal mice.
Diabetes 2001;50(6):1274-81.
2001: Yongsoo Park; H Lee; H Takino; Norio Abiru; Eiji Kawasaki; George S Eisenbarth
Evaluation of the efficacy of the combination of multiple autoantibodies to islet-specific antigens in Korean type 1 diabetic patients.
Acta diabetologica 2001;38(1):51-6.
2000: Norio Abiru; Dale R Wegmann; E Kawasaki; Peter A Gottlieb; EA Simone; George S Eisenbarth
Dual overlapping peptides recognized by insulin peptide B:9-23 T cell receptor AV13S3 T cell clones of the NOD mouse.
Journal of autoimmunity 2000;14(3):231-7.
2000: Liping Yu; David T Robles; Norio Abiru; P Kaur; Marian Rewers; Katalin Kelemen; George S Eisenbarth
Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(4):1701-6.
2000: Norio Abiru; G S Eisenbarth
Multiple genes/multiple autoantigens role in type 1 diabetes.
Clinical reviews in allergy & immunology 2000;18(1):27-40.
2000: Norio Abiru; Liping Yu; Maria J Redondo; M Redondo; George S Eisenbarth
Modification of the environment is not the most efficient way to prevent type 1 diabetes.
Diabetes technology & therapeutics 2000;2(4):609-16.
1999: Yasunori Sera; Eiji Kawasaki; Norio Abiru; Masako Ozaki; Takahiro Abe; H Takino; H Kondo; Hironori Yamasaki; Yoshihiko Yamaguchi; S Akazawa; Shigenobu Nagataki; Y Uchigata; N Matsuura; Katsumi Eguchi
Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening.
Journal of autoimmunity 1999;13(2):257-65.
1997: T Matsuba; M Yano; Norio Abiru; H Takino; S Akazawa; Shigenobu Nagataki; K Yasukawa
Expression of recombinant human glutamic acid decarboxylase (GAD) in myeloma cells and enzyme-linked immunosorbent assay (ELISA) for autoantibodies to GAD.
Journal of biochemistry 1997;121(1):20-4.
1996: Norio Abiru; H Takino; M Yano; Eiji Kawasaki; Hironori Yamasaki; Yoshihiko Yamaguchi; S Akazawa; S Nagataki
Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
Journal of autoimmunity 1996;9(5):683-8.
1996: K Matsumoto; Hironori Yamasaki; S Akazawa; H Sakamaki; M Ishibashi; Norio Abiru; S Uotani; H Matsuo; Yoshihiko Yamaguchi; K Tokuyama; S Nagataki
High-dose but not low-dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic beta-cells in normal men.
The Journal of clinical endocrinology and metabolism 1996;81(7):2621-6.
1996: Eiji Kawasaki; M Yano; Norio Abiru; S Akazawa; S Nagataki
Detection of recombinant GAD65 and GAD67 antibodies using a simple radioimmunoassay.
Diabetes research and clinical practice 1996;32(1-2):61-9.
1995: Eiji Kawasaki; Norio Abiru; M Yano; S Uotani; K Matsumoto; H Matsuo; Hironori Yamasaki; H Yamamoto; Yoshihiko Yamaguchi; S Akazawa
Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies.
Journal of autoimmunity 1995;8(5):633-43.
1994: K Matsumoto; S Akazawa; Norio Abiru; M Yano; M Ishibasi; S Uotani; H Matsuo; Eiji Kawasaki; Hironori Yamasaki; H Yamamoto
Insulin response after treatment depends on fasting plasma glucose level in NIDDM.
Diabetes research and clinical practice 1994;26(2):129-35.
1994: S Akawaza; Eiji Kawasaki; M Yano; Norio Abiru; Yoshihiko Yamaguchi; S Nagataki
Autoantibodies to glutamic acid decarboxylase (GAD), 64,000-Mr islet cell protein (64K) antibodies and islet cell antibodies (ICA) in insulin-dependent diabetes mellitus with and without autoimmune diseases in Japan.
Diabetes research and clinical practice 1994;24 Suppl():S89-93.